The National Comprehensive Cancer Network (NCCN) guidelines recommend BRCA1/2 testing in women diagnosed with breast cancer at age 45 and younger and those diagnosed with triple‐negative breast cancer at age 60 and younger 16. Here, BRCA1 is linked to breast carcinoma.